OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Smart Nanomedicine to Enable Crossing Blood–Brain Barrier Delivery of Checkpoint Blockade Antibody for Immunotherapy of Glioma
Hairong Wang, Yu Chao, He Zhao, et al.
ACS Nano (2022) Vol. 16, Iss. 1, pp. 664-674
Closed Access | Times Cited: 76
Hairong Wang, Yu Chao, He Zhao, et al.
ACS Nano (2022) Vol. 16, Iss. 1, pp. 664-674
Closed Access | Times Cited: 76
Showing 1-25 of 76 citing articles:
The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
Linghui Qian, Xuefen Lin, Xue Gao, et al.
Chemical Reviews (2023) Vol. 123, Iss. 12, pp. 7782-7853
Closed Access | Times Cited: 65
Linghui Qian, Xuefen Lin, Xue Gao, et al.
Chemical Reviews (2023) Vol. 123, Iss. 12, pp. 7782-7853
Closed Access | Times Cited: 65
Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 61
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 61
Tumor microenvironment targeting for glioblastoma multiforme treatment via hybrid cell membrane coating supramolecular micelles
Xiaobei Huang, Ning Mu, Yuan‐Fu Ding, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 194-203
Closed Access | Times Cited: 17
Xiaobei Huang, Ning Mu, Yuan‐Fu Ding, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 194-203
Closed Access | Times Cited: 17
Brain-Targeting Drug Delivery Systems: The State Of The Art In Treatment Of Glioblastoma
Bo Sun, Rong Li, Ning Ji, et al.
Materials Today Bio (2025) Vol. 30, pp. 101443-101443
Open Access | Times Cited: 2
Bo Sun, Rong Li, Ning Ji, et al.
Materials Today Bio (2025) Vol. 30, pp. 101443-101443
Open Access | Times Cited: 2
pH-responsive dissociable liposome/ferritin nanoparticles for treating acute epilepsy through regulating microvascular stabilization and remodeling inflammatory microenvironment
Yang Rong, Yage Sun, Xinrui Zhao, et al.
Nano Today (2025) Vol. 61, pp. 102652-102652
Closed Access | Times Cited: 2
Yang Rong, Yage Sun, Xinrui Zhao, et al.
Nano Today (2025) Vol. 61, pp. 102652-102652
Closed Access | Times Cited: 2
Antibody‐Incorporated Nanomedicines for Cancer Therapy
Shun‐Yu Wu, Fu‐Gen Wu, Xiaoyuan Chen
Advanced Materials (2022) Vol. 34, Iss. 24
Closed Access | Times Cited: 64
Shun‐Yu Wu, Fu‐Gen Wu, Xiaoyuan Chen
Advanced Materials (2022) Vol. 34, Iss. 24
Closed Access | Times Cited: 64
Stepwise Size Shrinkage Cascade‐Activated Supramolecular Prodrug Boosts Antitumor Immunity by Eliciting Pyroptosis
Mengyun Liang, Meng‐Jie Zhang, Wei Qiu, et al.
Advanced Science (2022) Vol. 9, Iss. 26
Open Access | Times Cited: 61
Mengyun Liang, Meng‐Jie Zhang, Wei Qiu, et al.
Advanced Science (2022) Vol. 9, Iss. 26
Open Access | Times Cited: 61
Salmonella-mediated blood‒brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo/bacterial glioma therapy
Ze Mi, Qing Yao, Yan Qi, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 819-833
Open Access | Times Cited: 51
Ze Mi, Qing Yao, Yan Qi, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 819-833
Open Access | Times Cited: 51
Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation
Haonan Li, Qiang Luo, Hu Zhang, et al.
Chemical Society Reviews (2022) Vol. 52, Iss. 1, pp. 47-96
Closed Access | Times Cited: 44
Haonan Li, Qiang Luo, Hu Zhang, et al.
Chemical Society Reviews (2022) Vol. 52, Iss. 1, pp. 47-96
Closed Access | Times Cited: 44
Highlighted Advances in Therapies for Difficult-To-Treat Brain Tumours Such as Glioblastoma
Nuno Cruz, Manuel Herculano-Carvalho, Diogo Roque, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 928-928
Open Access | Times Cited: 31
Nuno Cruz, Manuel Herculano-Carvalho, Diogo Roque, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 928-928
Open Access | Times Cited: 31
Melanin-Based Immunoregulatory Nanohybrids Enhance Antitumor Immune Responses in Breast Cancer Mouse Model
Kangli Guo, Zhuolong Jiao, Xiaoyi Zhao, et al.
ACS Nano (2023) Vol. 17, Iss. 11, pp. 10792-10805
Closed Access | Times Cited: 30
Kangli Guo, Zhuolong Jiao, Xiaoyi Zhao, et al.
ACS Nano (2023) Vol. 17, Iss. 11, pp. 10792-10805
Closed Access | Times Cited: 30
NIR‐II Perylene Monoimide‐Based Photothermal Agent with Strengthened Donor–Acceptor Conjugation for Deep Orthotopic Glioblastoma Phototheranostics
Jun Guan, Chang Liu, Chendong Ji, et al.
Small (2023) Vol. 19, Iss. 19
Closed Access | Times Cited: 27
Jun Guan, Chang Liu, Chendong Ji, et al.
Small (2023) Vol. 19, Iss. 19
Closed Access | Times Cited: 27
Graphdiyne nanoplatforms for photothermal-ferroptosis combination therapy against glioblastoma
Lingxiao Zhao, Zhiqiang Gong, Qi Zhang, et al.
Journal of Controlled Release (2023) Vol. 359, pp. 12-25
Closed Access | Times Cited: 27
Lingxiao Zhao, Zhiqiang Gong, Qi Zhang, et al.
Journal of Controlled Release (2023) Vol. 359, pp. 12-25
Closed Access | Times Cited: 27
Enhancing Methotrexate Delivery in the Brain by Mesoporous Silica Nanoparticles Functionalized with Cell-Penetrating Peptide using in Vivo and ex Vivo Monitoring
Nasim Shadmani, Pooyan Makvandi, Maliheh Parsa, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 3, pp. 1531-1548
Closed Access | Times Cited: 26
Nasim Shadmani, Pooyan Makvandi, Maliheh Parsa, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 3, pp. 1531-1548
Closed Access | Times Cited: 26
Recent progress, perspectives, and issues of engineered PD-L1 regulation nano-system to better cure tumor: A review
Zaigang Zhou, Haoxiang Wang, Jie Li, et al.
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127911-127911
Closed Access | Times Cited: 25
Zaigang Zhou, Haoxiang Wang, Jie Li, et al.
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127911-127911
Closed Access | Times Cited: 25
Brain Delivery of Biomimetic Phosphorus Dendrimer/Antibody Nanocomplexes for Enhanced Glioma Immunotherapy via Immune Modulation of T Cells and Natural Killer Cells
Yamin Peng, Mengsi Zhan, Andrii Karpus, et al.
ACS Nano (2024) Vol. 18, Iss. 14, pp. 10142-10155
Closed Access | Times Cited: 12
Yamin Peng, Mengsi Zhan, Andrii Karpus, et al.
ACS Nano (2024) Vol. 18, Iss. 14, pp. 10142-10155
Closed Access | Times Cited: 12
Metal‐Coordinated NIR‐II Nanoadjuvants with Nanobody Conjugation for Potentiating Immunotherapy by Tumor Metabolism Reprogramming
Yeneng Dai, Ziang Guo, Dongliang Leng, et al.
Advanced Science (2024)
Open Access | Times Cited: 9
Yeneng Dai, Ziang Guo, Dongliang Leng, et al.
Advanced Science (2024)
Open Access | Times Cited: 9
Stimuli-Responsive Polymeric Nanomedicine for Enhanced Cancer Immunotherapy
Chan Ho Kim, Kyu Eun Lee, Hyewon Ko, et al.
Chemistry of Materials (2024) Vol. 36, Iss. 3, pp. 1088-1112
Closed Access | Times Cited: 8
Chan Ho Kim, Kyu Eun Lee, Hyewon Ko, et al.
Chemistry of Materials (2024) Vol. 36, Iss. 3, pp. 1088-1112
Closed Access | Times Cited: 8
Neutrophil-based Trojan horse containing polymer nano-therapeutics for sono-activatable ferroptosis-immunotherapy of orthotopic glioma
Mengbin Ding, Anni Zhu, Yijing Zhang, et al.
Nano Today (2024) Vol. 57, pp. 102398-102398
Closed Access | Times Cited: 8
Mengbin Ding, Anni Zhu, Yijing Zhang, et al.
Nano Today (2024) Vol. 57, pp. 102398-102398
Closed Access | Times Cited: 8
Advanced Nanoparticle Engineering for Precision Therapeutics of Brain Diseases
Muhammad Ismail, Jiayi Liu, Ningyang Wang, et al.
Biomaterials (2025) Vol. 318, pp. 123138-123138
Closed Access | Times Cited: 1
Muhammad Ismail, Jiayi Liu, Ningyang Wang, et al.
Biomaterials (2025) Vol. 318, pp. 123138-123138
Closed Access | Times Cited: 1
Granzyme B Turns Nanoparticle Fluorescence “On” for Imaging Cytotoxic T Lymphocyte Activity in Vivo
Lingling Xu, Nanhui Liu, Wenjun Zhan, et al.
ACS Nano (2022) Vol. 16, Iss. 11, pp. 19328-19334
Closed Access | Times Cited: 37
Lingling Xu, Nanhui Liu, Wenjun Zhan, et al.
ACS Nano (2022) Vol. 16, Iss. 11, pp. 19328-19334
Closed Access | Times Cited: 37
Brain‐targeting drug delivery systems
Peixin Liu, Chen Jiang
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2022) Vol. 14, Iss. 5
Closed Access | Times Cited: 35
Peixin Liu, Chen Jiang
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2022) Vol. 14, Iss. 5
Closed Access | Times Cited: 35
Nanoparticle Targeting with Antibodies in the Central Nervous System
Ju-Hyun Lee, Dana V. Chapman, W. Mark Saltzman
BME Frontiers (2023) Vol. 4
Open Access | Times Cited: 20
Ju-Hyun Lee, Dana V. Chapman, W. Mark Saltzman
BME Frontiers (2023) Vol. 4
Open Access | Times Cited: 20
Nanobiotechnology-based treatment strategies for malignant relapsed glioma
Qiujun Qiu, Xinyi Ding, Jixiang Chen, et al.
Journal of Controlled Release (2023) Vol. 358, pp. 681-705
Closed Access | Times Cited: 19
Qiujun Qiu, Xinyi Ding, Jixiang Chen, et al.
Journal of Controlled Release (2023) Vol. 358, pp. 681-705
Closed Access | Times Cited: 19
Intelligent delivery system targeting PD-1/PD-L1 pathway for cancer immunotherapy
Ning Liu, Renshuai Zhang, Qiang Shi, et al.
Bioorganic Chemistry (2023) Vol. 136, pp. 106550-106550
Closed Access | Times Cited: 18
Ning Liu, Renshuai Zhang, Qiang Shi, et al.
Bioorganic Chemistry (2023) Vol. 136, pp. 106550-106550
Closed Access | Times Cited: 18
